Combined Phacoemulsification and 360-Degree Suture Trabeculotomy Ab Externo in Primary Chronic Angle Closure Glaucoma: A Modified Technique

原发性慢性闭角型青光眼超声乳化联合360度缝线外路小梁切开术:一种改良技术

阅读:1

Abstract

PURPOSE: To assess the outcome of combined phacoemulsification and 360-degree suture trabeculotomy ab externo in chronic angle closure glaucoma using a modified technique. METHODS: This is a retrospective clinical study that included 60 eyes of 60 patients who had undergone combined phacoemulsification and 360-degree suture trabeculotomy ab externo for the treatment of primary chronic angle closure glaucoma. The patients were divided into two groups. The first group (ab externo group) and the second group (modified ab externo group). Data were collected from the records and the final follow-up visit including age, sex, intraocular pressure (IOP), number of antiglaucoma medications, presence of complications, corrected distant visual acuity, and need for another intervention. All the included patients completed at least 12 months follow-up. RESULTS: The ab externo group included 30 patients and the modified ab externo group included 30 patients. The postoperative IOP was reduced in both groups significantly from the preoperative levels. The percent of reduction was around 60% for both groups (59.5% for the ab externo group and 59.3% for the modified ab externo group). There was statistically significant reduction in the mean amount of required topical medications after the intervention for both groups (p = 0.001). Most of the complications were not serious. Around 90% of the cases in both groups had mild degree of grade 1 hyphema. CONCLUSION: Both ab externo 360 degree suture trabeculotomy and its modified technique with ab interno pulling of the suture when combined with phacoemulsification are safe and provide adequate decrease in the intraocular pressure. Modified technique of ab interno pulling of the prolene suture might be more gentle procedure with less severe hyphema and lower chance of rupture of trabeculo-Descemet's membrane.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。